Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ryvu Therapeutics is a publicly listed Polish biotechnology company based in Kraków. It discovers and develops small-molecule drug candidates for oncology, advancing novel cancer therapies through early-stage clinical research.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ryvu Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ryvu Therapeutics last reported quarterly earnings on 9/17/2026 (Q2 2026).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.